PHARMA & LIFE SCIENCES: LATEST INTERVIEWS MORE INTERVIEWS

"Certainly, the way healthcare is consumed has changed forever with people looking for convenient on-site and at-home solutions for care and we see this accelerating."
"Our mission will remain to provide reliable, efficient, and safe processes from development, aseptic filling, and visual inspection to parenteral packaging in an economically, ethically, and ecologically responsible manner."
"Our mission is to bring novel and transformative therapies to the anterior (front) chamber of the eye, particularly for the treatment of ocular surface disease."
"Although each rare disease impacts a small population, the rare disease population is estimated to be 10% of the total population, meaning 25-30 million Americans have at least one rare condition."

PHARMA & LIFE SCIENCES: LATEST ARTICLES

Funding Environment: Life Sciences Enter the Mainstream

April 20, 2021
The past 12 months been transformative for the life science industry in USA, and GBR explores how the funding environment has evolved to provide the influx of capital to sustain its innovations.

Turkey Pharmaceuticals: Bringing All Actors Together

June 17, 2020
Industry, university, investors - the two-way bridge to the knowledge gap.

PHARMA & LIFE SCIENCES: RECENTLY RELEASED PUBLICATIONS

MACIG

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

Qu├ębec Mining 2022 - Digital Version

PARTNER EVENTS